Literature DB >> 223138

The pathogenesis of respiratory viral infection.

R B Heath.   

Abstract

Sendai virus is used as a model to study the histological response and the mechanism of recovery of mice from infection. Although mice infected intranasally do not appear ill, the ciliated columnar cells of the bronchial epithelium undergoes rapid necrosis followed later by repair. Interferon is produced at an early stage of infection and antibody formation follows later. Cyclophosphamide given to mice infected with Sendai virus abolishes the humoral antibody response but not interferon production; the mice develop pneumonic lesions. They cannot eliminate virus and they die. On the other hand, deprivation of 'T' lymphocytes by thymectomy, irradiation and bone marrow reconstitution renders mice more susceptible to Sendai virus but they do not die. The humoral response is thus apparently helped by 'T' lymphocytes and interferon production is not vital for recovery.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223138      PMCID: PMC2425370          DOI: 10.1136/pgmj.55.640.122

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

1.  Cell-mediated immunity to Sendai virus infection in mice.

Authors:  M J Anderson; D R Bainbridge; J R Pattison; R B Heath
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

2.  Studies on the immune response and pathogenesis of Sendai virus infection of mice. II. The immunoglobulin class of plasma cells in the bronchial sub-mucosa.

Authors:  G Blandford; R B Heath
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

3.  Parainfluenza virus Sendai infection in macrophages, ependyma, choroid plexus, vascular endothelium and respiratory tract of mice.

Authors:  C A Mims; F A Murphy
Journal:  Am J Pathol       Date:  1973-03       Impact factor: 4.307

4.  Studies of the immune respnse in Sendai virus infection of mice.

Authors:  G Blandford; R J Cureton; R B Heath
Journal:  J Med Microbiol       Date:  1971-08       Impact factor: 2.472

5.  Studies on the immune response and pathogenesis of Sendai virus infection of mice. I. The fate of viral antigens.

Authors:  G Blandford; R B Heath
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

6.  The effect of cyclophosphamide on Sendai virus infection of mice.

Authors:  T W Robinson; R J Cureton; R B Heath
Journal:  J Med Microbiol       Date:  1969-05       Impact factor: 2.472

7.  Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza.

Authors:  M Degré; L A Glasgow
Journal:  J Infect Dis       Date:  1968-12       Impact factor: 5.226

8.  The pathogenesis of Sendai virus infection in the mouse lung.

Authors:  T W Robinson; R J Cureton; R B Heath
Journal:  J Med Microbiol       Date:  1968-08       Impact factor: 2.472

9.  The pathogenesis of infections of the mouse caused by virulent and avirulent variants of an influenza virus.

Authors:  S Raut; J Hurd; G Blandford; R B Heath; R J Cureton
Journal:  J Med Microbiol       Date:  1975-02       Impact factor: 2.472

10.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody.

Authors:  J L Virelizier
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

View more
  3 in total

1.  Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor.

Authors:  A Opgenorth; K Graham; N Nation; D Strayer; G McFadden
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages.

Authors:  N J Roberts
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

3.  Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.

Authors:  M Tashiro; Y Fujii; K Nakamura; M Homma
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.